Hydroxyamine hydrochloride → (S)-N-{3-[3-fluoro-4-(4-hydroxyimino-piperidin-1-yl)-phenyl]-2-oxo oxazolidin-5-ylmethyl}-acetamide
反応式
C([O-])(=O)C.[Na+].Cl.[NH2:7][OH:8].[F:9][C:10]1[CH:11]=[C:12]([N:23]2[CH2:27][C@H:26]([CH2:28][NH:29][C:30](=[O:32])[CH3:31])[O:25][C:24]2=[O:33])[CH:13]=[CH:14][C:15]=1[N:16]1[CH2:21][CH2:20][C:19](=O)[CH2:18][CH2:17]1>CO.C(Cl)Cl>[F:9][C:10]1[CH:11]=[C:12]([N:23]2[CH2:27][C@H:26]([CH2:28][NH:29][C:30](=[O:32])[CH3:31])[O:25][C:24]2=[O:33])[CH:13]=[CH:14][C:15]=1[N:16]1[CH2:21][CH2:20][C:19](=[N:7][OH:8])[CH2:18][CH2:17]1参加物
5
反応物 3
生成物 1
試薬・触媒・溶媒 1
実験手順
Sodium acetate (517 mg) and hydroxylamine hydrochloride (219 mg) are successively added to a methanol-methylene chloride solution (10--10 ml) of 1.00 g of the product of Step 2, and the mixture is stirred at room temperature for 2 days. The solvent is evaporated and the residue is dissolved in methanol, followed by addition of a silica gel (8 g). Methanol is evaporated and the residue is purified by silica gel column chromatography (solvent: chloroform/methanol=50/1-25/1) to afford the title compound.
後処理
- customThe solvent is evaporated
- dissolutionthe residue is dissolved in methanol
- additionfollowed by addition of a silica gel (8 g)
- customMethanol is evaporated
- customthe residue is purified by silica gel column chromatography (solvent: chloroform/methanol=50/1-25/1)
出典と根拠
- ORDレコード
- ord-8bc02a089ff34d259d06e5d38b6f5b06
- 出典データセット
- uspto-grants-1999_12
- 特許番号
- US05998406
反応ノート
読み込み中…